MEDICALIP LOGO

MEDICAL IP to attract investment in Series C... Partnership with Dong-A Socio Holdings

MEDICAL IP attracts 20 billion KRW Series C investment

▶ Expected to strengthen competitiveness in the medical market through partnership with Dong-A Socio Holdings, which participated in SI

Medicalip Series C

MEDICALIP has completed attracting 20 billion won of Series C investment.

In particular, Dong-A Socio Holdings, which has many affiliates in the medical field such as Dong-A ST and Dong-A Pharmaceutical, participated as a strategic investor in this investment MEDICAL IP expected to strengthen competitiveness in the medical field and expand the market in earnest.

Dong-A Socio Holdings plans to join with MEDICALIP to foster artificial intelligence healthcare business and create new business opportunities.

CEO Park Sang-joon said, “MEDICALIP is building a differentiated business model that can predict and even monitor diseases using medical AI.”

He continued, “Both FI and SI highly evaluated the company’s technological competitiveness, and we successfully attracted a total of KRW 20 billion in investment. By using this, we will strive to advance the technology, commercialize medical AI products, and enter the global healthcare market.”

LATEST NEWS

Article
Jun 18 / 2024

[MedTech] 'Augmented Reality' Enters the Operating Room, Providing '3D Color Visualization' from 2D Flat Medical Image

Article
Jun 18 / 2024

MEDICAL IP participated in ‘HIMSS 2024 Europe,’ introducing their personalized liver cancer solutions.

Article
Mar 7 / 2024

MEDICAL IP, selected as “Top 10 R&D in cross-government medical devices of 2024 KMDF” through Extended Reality Technology

1/48

Questions on our public relations?

Ask us now.